These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6316855)

  • 1. [Antitumor effect of human fibroblast interferon in hepatocellular carcinoma].
    Okai T
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2532-7. PubMed ID: 6316855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumoral effect of gamma-interferon in patients with hepatocellular carcinoma].
    Kanda Y; Futatsugi K; Saifuku K; Kuwatsuru R; Akazawa S; Fujiki T; Yamamoto K; Yoon S; Ishii M; Nakajima T
    Gan No Rinsho; 1988 Aug; 34(9):1073-8. PubMed ID: 2459429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council Study.
    Harris J; Das Gupta T; Vogelzang N; Badrinath K; Bonomi P; Desser R; Locker G; Blough R; Johnson C
    Cancer Treat Rep; 1986 Feb; 70(2):293-4. PubMed ID: 3948193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of human fibroblast interferon on malignant brain tumors].
    Nakamura O; Teramoto A; Yamamoto H; Ochiai C; Takakura K; Maruo K; Ueyama Y; Shimamura K
    No To Shinkei; 1983 Sep; 35(9):905-11. PubMed ID: 6651989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?
    Tanaka K; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Oncol Rep; 1998; 5(1):205-8. PubMed ID: 9458323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intra arterial infusion chemotherapy combined with interferon-alpha following palliative hepatic resection against advanced hepatoma with portal venous tumor thrombus in the major trunk and multiple nodules--a preliminary study].
    Nagano H; Miyamoto A; Wada H; Noda T; Nakamura M; Ota H; Damdinsuren B; Marubashi S; Takeda Y; Umeshita K; Dono K; Monden M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1848-51. PubMed ID: 17212125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
    Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
    Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
    Chaplinski T; Laszlo J; Moore J; Silverman P
    Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
    Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
    Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy.
    Tokita H; Fukui H; Tanaka A; Kamitsukasa H; Yagura M; Harada H; Okamoto H
    J Gastroenterol Hepatol; 2005 May; 20(5):752-8. PubMed ID: 15853990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.
    Murata M; Nabeshima S; Kikuchi K; Yamaji K; Furusyo N; Hayashi J
    Cytokine; 2006 Feb; 33(3):121-8. PubMed ID: 16522372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer.
    Ikeda K; Arase Y; Saitoh S; Kobayashi M; Suzuki Y; Suzuki F; Tsubota A; Chayama K; Murashima N; Kumada H
    Hepatology; 2000 Aug; 32(2):228-32. PubMed ID: 10915728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors.
    Lin SM; Lin CJ; Hsu CW; Tai DI; Sheen IS; Lin DY; Liaw YF
    Cancer; 2004 Jan; 100(2):376-82. PubMed ID: 14716774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effects of human fibroblast interferon in advanced gynecological cancers].
    Kanazawa K; Honma S; Yuzawa H; Takeuchi S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1276-83. PubMed ID: 6732254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.